June M McKoy

  • 3744 Citations
20032020
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

My primary research foci are in the areas of cancer survivorship, cancer pharmacoeconomics, comparative effectiveness analyses, HIV and cancer, and adverse drug reactions in older individuals living with cancer.

Certifications and Licenses

Geriatric Medicine

Training Experience

1992Residency, Univ. of Illinois Hospital
1995Residency, Univ. of Illinois Hospital
2001Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

MBA, Kellogg School of Management

… → 2010

JD, DePaul University

… → 2001

MPH, University of Illinois - Chicago

… → 1999

MD, Southern Illinois University

… → 1989

Keywords

  • Aging
  • Geriatrics
  • Osteoporosis
  • Patient Safety
  • Pharmacology
  • Preventive Medicine
  • Public Policy
  • Underserved Medicine

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 6 Similar Profiles
Drug-Related Side Effects and Adverse Reactions Medicine & Life Sciences
United States Food and Drug Administration Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
clopidogrel Medicine & Life Sciences
Research Medicine & Life Sciences
Pharmacovigilance Medicine & Life Sciences
Thrombotic Thrombocytopenic Purpura Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2003 2020

Research
Neoplasms
Students
Organized Financing
Community-Institutional Relations
aging population
stakeholder
quality of life
indicator
prioritization
evaluation
WHO
community
leader
innovator

Research Output 2004 2019

Anatomy of risk evaluation and mitigation strategies (REMS)

Loeser, K. K., McKoy, J. M. & Schumock, G. T., Jan 1 2019, Cancer Treatment and Research. Springer International Publishing, p. 93-105 13 p. (Cancer Treatment and Research; vol. 171).

Research output: Chapter in Book/Report/Conference proceedingChapter

Anatomy
Pharmacovigilance

Biosimilars: Are they really safe?

McKoy, J. M. & Giles, F. J., Jan 1 2019, Cancer Treatment and Research. Springer International Publishing, p. 61-73 13 p. (Cancer Treatment and Research; vol. 171).

Research output: Chapter in Book/Report/Conference proceedingChapter

Biosimilar Pharmaceuticals
Cost Savings
Safety
Research
Neoplasms

Cancer comorbidity: Implications for drug safety

O’Brien, K., McKoy, J. M. & Penedo, F., Jan 1 2019, Cancer Treatment and Research. Springer International Publishing, p. 21-35 15 p. (Cancer Treatment and Research; vol. 171).

Research output: Chapter in Book/Report/Conference proceedingChapter

Comorbidity
Safety
Pharmaceutical Preparations
Neoplasms

Cancer drug toxicity: Moving from patient to survivor

Slocum, M., Garcia, S. F. & McKoy, J. M., Jan 1 2019, Cancer Treatment and Research. Springer International Publishing, p. 107-118 12 p. (Cancer Treatment and Research; vol. 171).

Research output: Chapter in Book/Report/Conference proceedingChapter

Moving and Lifting Patients
Drug-Related Side Effects and Adverse Reactions
Neoplasms
Early Detection of Cancer
Safety

Moonshot to cancer cure: Recruiting policy to break down silos

Simon, M. A., Cordova, E. & McKoy, J. M., Jan 1 2019, Cancer Treatment and Research. Springer International Publishing, p. 119-128 10 p. (Cancer Treatment and Research; vol. 171).

Research output: Chapter in Book/Report/Conference proceedingChapter

Neoplasms
Research
Bidens
Public-Private Sector Partnerships
Drug Therapy